Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Chlorisondamine and Niacin

supplement:

Niacin

Research Papers that Mention the Interaction

Nicotinic blockade in vivo was attempted with either the classical antagonist chlorisondamine or the novel antagonist catestatin.
Journal of Biological Chemistry  •  2003  |  View Paper
Chlorisondamine , a long-lasting nicotinic acetylcholine receptor antagonist, reverted significantly the nicotinic protective effects on dopamine concentrations.
Brain Research  •  2001  |  View Paper
These findings suggest that chlorisondamine blocks nicotinic effects widely within the brain.
British journal of pharmacology  •  2000  |  View Paper
4 Both in vitro and in vivo administration of chlorisondamine blocked nicotinic responses to acetylcholine (10−4 m).
British journal of pharmacology  •  1994  |  View Paper
These results support findings from other behavioural procedures indicating that centrally administered chlorisondamine causes a long-term blockade of central nicotinic mechanisms.
Neuropharmacology  •  1986  |  View Paper
Treatment with chlorisondamine , which blocks nicotinic ganglionic transmission, also increased SP, reproducing the effects of decentralization.
Brain Research  •  1982  |  View Paper
The cholinergic response is nicotinic and blocked by pentolinium, hexamethonium, chlorisondamine and dihydro-beta-erythroidine.
Comparative biochemistry and physiology. C: Comparative pharmacology  •  1982  |  View Paper
produced a small but significant reduction of the pressor response to lumbar electrical stimulation prior and following blockade of nicotinic transmission with chlorisondamine (1.0 mg/kg).
European journal of pharmacology  •  1978  |  View Paper
Combined nicotinic ganglion blockade by chlorisondamine (1 mg/kg) and muscarinic ganglion blockade by atropine (50mug/kg) abolished the reflex vasomotor response but did not alter hindlimb peripheral resistance.
Nicotinic ganglion blockade by chlorisondamine (1 mg/kg) significantly reduced reflex vasomotor responses but did not significantly alter hindlimb peripheral resistance.
European journal of pharmacology  •  1975  |  View Paper